, determinants, and impact of delays in HCC care is timely in light of the ongoing COVID-19 pandemic and its impact on healthcare delivery. In a recent American Cancer Society survey, 50% of patients with cancer reported disrupted access to healthcare, including
Search Results
Ashwin Rao, Nicole E. Rich, Jorge A. Marrero, Adam C. Yopp, and Amit G. Singal
Alexa Wilden, Aishwarya Sannareddy, Hetal Patel, Shraddha Kansagra, Gurbakhash Kaur, Praveen Ramakrishnan, Prapti Patel, Ansh Mehta, and Ankit Kansagra
two monoclonal antibodies (MAbs), casirivimab/imdevimab and bamlanivimab, for treating mild/moderate COVID-19. In this real-world retrospective study, we aim to evaluate the efficacy of monoclonal antibody therapy in patients with and without a history
Rihab Melliti, R. Melliti, S. Tbessi, A. Chamsi, H. Ouaz, F. Bouguerra, S. Belajouza, N. Bouzid, and S. Tebra
INTRODUCTION : Coronavirus vaccination is strongly recommended for cancer patients. However, there is a limited data regarding cancer patients’ attitudes towards COVID -19 vaccination. We aim to evaluate cancer patients’ willingness to take
Nayha Tahir, Grace Ying, Sonika Prasad, and Aatma Ram
have an active mammogram order in their chart given they were either due for an annual exam or declined new order. The remaining 57 patients did not complete their mammogram for various reasons. These included but not limited to COVID-19 pandemic
Coronavirus Disease 2019 (COVID-19) Resources for the Cancer Care Community NCCN recognizes the rapidly changing medical information relating to COVID-19 in the oncology ecosystem, but understands that a forum for sharing best practices and specific
many personal stories our staff submitted for inclusion in our World Cancer Day challenge.” Over the past 12 months, NCCN has also worked to maintain and optimize quality cancer care during the ongoing COVID-19 pandemic. This work includes guidance
Information on Third mRNA COVID-19 Vaccine Dose Added to NCCN Guidance for People With Cancer NCCN announced significant updates to the NCCN: Cancer and COVID-19 Vaccination guidance. This is the fourth version of NCCN’s COVID-19 vaccination
Emily A. Harlan and Andrew G. Shuman
COVID-19 pandemic. 1 Drug shortages are a systematic problem: a manifestation of perverse incentives for pharmaceutical companies and other stakeholders, and of the fundamentally broken healthcare system in which we work. Drug shortages are often a
NCCN 2021 Virtual Annual Conference Addresses Cancer Care in a Year of Crisis and Innovation New recommendations to advance racial equity, ways to mitigate the impacts of the COVID-19 pandemic on cancer care, and ongoing strategies for
NCCN Updates Recommendations for COVID-19 Vaccination With Information on Bivalent Vaccines, Children With Cancer, and Other Developments NCCN has released updated recommendations from the NCCN Advisory Committee on COVID-19 Vaccination and
